Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

The effect of moderate alcohol drinking in nonalcoholic fatty liver disease

Jong Hwa Choi, Won Sohn, Yong Kyun Cho

Clin Mol Hepatol. 2020;26(4):662-669. Published online September 25, 2020

DOI: https://doi.org/10.3350/cmh.2020.0163

View: 8538 Download: 164 Web of Science: 33 Crossref: 32

Inter-professional and inter-departmental alcoholism rehabilitation program

Masahiro Kikuchi, Naomi Matsutani, Ryota Ishihara, Masako Sugihara, Yuuki Mizuno, Chiyo Chiba, Takahiro Ohta, Eri Yamada, Sota Oguro, Yasuko Sato, Hiroki Bessho, Yoshinori Horie

Clin Mol Hepatol. 2020;26(4):626-632. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0151

View: 3900 Download: 65 Web of Science: 1 Crossref: 1

Programmed cell death in alcohol-associated liver disease

Tatsunori Miyata, Laura E. Nagy

Clin Mol Hepatol. 2020;26(4):618-625. Published online September 21, 2020

DOI: https://doi.org/10.3350/cmh.2020.0142

View: 10527 Download: 268 Web of Science: 40 Crossref: 44

From intestinal dysbiosis to alcohol-associated liver disease

Beatriz Garcia Mendes, Bernd Schnabl

Clin Mol Hepatol. 2020;26(4):595-605. Published online September 11, 2020

DOI: https://doi.org/10.3350/cmh.2020.0086

View: 7800 Download: 225 Web of Science: 20 Crossref: 23

Letter to the Editor

Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?

Dimitrios Patoulias, Michael Doumas

Clin Mol Hepatol. 2020;26(4):582-583. Published online September 25, 2020

DOI: https://doi.org/10.3350/cmh.2020.0264

View: 3448 Download: 66 Web of Science: 2 Crossref: 2

Original Article

Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea

Yu Rim Lee, Min Kyu Kang, Jeong Eun Song, Hyun Jung Kim, Young Oh Kweon, Won Young Tak, Se Young Jang, Jung Gil Park, Changhyeong Lee, Jae Seok Hwang, Byoung Kuk Jang, Jeong Ill Suh, Woo Jin Chung, Byung Seok Kim, Soo Young Park

Clin Mol Hepatol. 2020;26(4):562-576. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0126

View: 6371 Download: 181 Web of Science: 22 Crossref: 23

Acute-on-chronic liver failure as a major predictive factor for mortality in patients with variceal bleeding

Jongbeom Shin, Jung Hwan Yu, Young-Joo Jin, Hyung Joon Yim, Young Kul Jung, Jin Mo Yang, Do Seon Song, Young Seok Kim, Sang Gyune Kim, Dong Joon Kim, Ki Tae Suk, Eileen L. Yoon, Sang Soo Lee, Chang Wook Kim, Hee Yeon Kim, Jae Young Jang, Soung Won Jeong

Clin Mol Hepatol. 2020;26(4):540-553. Published online September 17, 2020

DOI: https://doi.org/10.3350/cmh.2020.0034

View: 6420 Download: 182 Web of Science: 23 Crossref: 23

Editorial

More evidence that direct acting antiviral therapy is safe and effective in cirrhosis and chronic kidney disease including peritoneal dialysis

Paul Kwo, Deepti Dronamraju

Clin Mol Hepatol. 2020;26(4):489-491. Published online September 24, 2020

DOI: https://doi.org/10.3350/cmh.2020.0228

View: 3754 Download: 68 Web of Science: 1 Crossref: 1

Acute-on-chronic liver failure: A predictor of poor prognosis in patients with variceal bleeding or a risk factor for variceal bleeding?

Nae-Yun Heo

Clin Mol Hepatol. 2020;26(4):487-488. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0209

View: 3627 Download: 95 Web of Science: 2 Crossref: 2

Review

Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology

Silvia Sookoian, Carlos J. Pirola

Clin Mol Hepatol. 2020;26(4):461-475. Published online September 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0136

View: 8203 Download: 276 Web of Science: 34 Crossref: 37

Managing liver cirrhotic complications: Overview of esophageal and gastric varices

Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani

Clin Mol Hepatol. 2020;26(4):444-460. Published online October 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0022

View: 12163 Download: 673 Web of Science: 50 Crossref: 55

Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease

Kyung-Soo Kim, Byung-Wan Lee

Clin Mol Hepatol. 2020;26(4):430-443. Published online August 14, 2020

DOI: https://doi.org/10.3350/cmh.2020.0137

View: 9680 Download: 475 Web of Science: 35 Crossref: 35

Liver graft from donation after circulatory death donor: Real practice to improve graft viability

Koji Hashimoto

Clin Mol Hepatol. 2020;26(4):401-410. Published online July 10, 2020

DOI: https://doi.org/10.3350/cmh.2020.0072

View: 5700 Download: 152 Web of Science: 7 Crossref: 8

Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH

Theresa J. Hydes, Sujan Ravi, Rohit Loomba, Meagan E. Gray

Clin Mol Hepatol. 2020;26(4):383-400. Published online July 17, 2020

DOI: https://doi.org/10.3350/cmh.2020.0067

View: 10118 Download: 511 Web of Science: 46 Crossref: 48

Original Article

Low-level viremia and cirrhotic complications in patients with chronic hepatitis B according to adherence to entecavir

Seung Bum Lee, Joonho Jeong, Jae Ho Park, Seok Won Jung, In Du Jeong, Sung-Jo Bang, Jung Woo Shin, Bo Ryung Park, Eun Ji Park, Neung Hwa Park

Clin Mol Hepatol. 2020;26(3):364-375. Published online May 29, 2020

DOI: https://doi.org/10.3350/cmh.2020.0012

View: 5814 Download: 267 Web of Science: 24 Crossref: 21

Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment

Cheol-Hyung Lee, Yun Bin Lee, Minseok Albert Kim, Heejoon Jang, Hyunwoo Oh, Sun Woong Kim, Eun Ju Cho, Kyung-Hun Lee, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Tae-You Kim, Yoon Jun Kim

Clin Mol Hepatol. 2020;26(3):328-339. Published online May 28, 2020

DOI: https://doi.org/10.3350/cmh.2019.0049n

View: 8344 Download: 336 Web of Science: 30 Crossref: 31

Clinical application of ultrasonography-guided percutaneous liver biopsy and its safety over 18 years

Young Chang, Jun Il Kim, Bora Lee, Sang Gyune Kim, Min Jung Jung, Young Seok Kim, Soung Won Jeong, Jae Young Jang, Jeong-Ju Yoo

Clin Mol Hepatol. 2020;26(3):318-327. Published online May 25, 2020

DOI: https://doi.org/10.3350/cmh.2019.0019n

View: 6093 Download: 249 Web of Science: 18 Crossref: 18

Editorial

Low-level viremia in patients undergoing antiviral therapy: Does it indicate time for a change?

Jung Hee Kim, Dong Hyun Sinn

Clin Mol Hepatol. 2020;26(3):315-317. Published online June 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0084

View: 4583 Download: 103 Crossref: 1

Review

Fecal microbiota transplantation in alcohol related liver diseases

Saggere Muralikrishna Shasthry

Clin Mol Hepatol. 2020;26(3):294-301. Published online June 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0057

View: 7014 Download: 210 Web of Science: 19 Crossref: 23

Special Topic

Management of liver diseases during the pandemic of coronavirus disease-19

Ju-Yeon Cho, Soon Sun Kim, Young-Sun Lee, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim

Clin Mol Hepatol. 2020;26(3):243-250. Published online June 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0111

View: 7042 Download: 231 Web of Science: 8 Crossref: 7

Original Article

Limited expression of TLR9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease

Nadia Soledad Alegre, Cecilia Claudia Garcia, Luis Ariel Billordo, Beatriz Ameigeiras, Daniel Poncino, Javier Benavides, Luis Colombato, Alejandra Claudia Cherñavsky

Clin Mol Hepatol. 2020;26(2):216-226. Published online December 5, 2019

DOI: https://doi.org/10.3350/cmh.2019.0074

View: 6555 Download: 140 Web of Science: 14 Crossref: 12

Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017

Seung Ha Park, Lindsay D. Plank, Ki Tae Suk, Yong Eun Park, Jin Lee, Joon Hyuk Choi, Nae Yun Heo, Jongha Park, Tae Oh Kim, Young Soo Moon, Hyun Kuk Kim, Hang Jea Jang, Ha Young Park, Dong Joon Kim

Clin Mol Hepatol. 2020;26(2):209-215. Published online November 4, 2019

DOI: https://doi.org/10.3350/cmh.2019.0065

View: 33795 Download: 403 Web of Science: 76 Crossref: 79

Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma

Rahul Kumar, Boon-Bee George Goh, Jia-Wen Kam, Pik-Eu Chang, Chee-Kiat Tan

Clin Mol Hepatol. 2020;26(2):196-208. Published online January 9, 2020

DOI: https://doi.org/10.3350/cmh.2019.0012

View: 8019 Download: 269 Web of Science: 14 Crossref: 14

Editorial

Toll-like receptor 9, a possible blocker of non-alcoholic steatohepatitis?

Soung Won Jeong

Clin Mol Hepatol. 2020;26(2):185-186. Published online March 23, 2020

DOI: https://doi.org/10.3350/cmh.2020.0046

View: 4325 Download: 87 Web of Science: 1 Crossref: 1

Should you advocate for hepatocellular carcinoma surveillance in patients with alcohol-related liver disease or non-alcoholic fatty liver disease?

Ju Hyun Shim

Clin Mol Hepatol. 2020;26(2):183-184. Published online March 12, 2020

DOI: https://doi.org/10.3350/cmh.2020.0042

View: 4198 Download: 111 Web of Science: 6 Crossref: 6

Review

Switching to systemic therapy after locoregional treatment failure: Definition and best timing

Sadahisa Ogasawara, Yoshihiko Ooka, Keisuke Koroki, Susumu Maruta, Hiroaki Kanzaki, Kengo Kanayama, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Tomoko Saito, Takayuki Kondo, Eiichiro Suzuki, Shingo Nakamoto, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Jun Kato, Naoya Kato

Clin Mol Hepatol. 2020;26(2):155-162. Published online January 15, 2020

DOI: https://doi.org/10.3350/cmh.2019.0021n

View: 9757 Download: 408 Web of Science: 41 Crossref: 38

Drug induced liver injury: East versus West – a systematic review and meta-analysis

En Xian Sarah Low, Qishi Zheng, Edwin Chan, Seng Gee Lim

Clin Mol Hepatol. 2020;26(2):142-154. Published online December 10, 2019

DOI: https://doi.org/10.3350/cmh.2019.1003

View: 9096 Download: 530 Web of Science: 24 Crossref: 26

Application of transient elastography in nonalcoholic fatty liver disease

Xinrong Zhang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong

Clin Mol Hepatol. 2020;26(2):128-141. Published online November 8, 2019

DOI: https://doi.org/10.3350/cmh.2019.0001n

View: 13879 Download: 561 Web of Science: 59 Crossref: 63

Original Article

Sensitivity of ultrasound in detecting hepatocellular carcinoma in obese patients compared to explant pathology as the gold standard

Jamak Modaresi Esfeh, Kaveh Hajifathalian, Kianoush Ansari-Gilani

Clin Mol Hepatol. 2020;26(1):54-59. Published online November 15, 2019

DOI: https://doi.org/10.3350/cmh.2019.0039

View: 8185 Download: 188 Web of Science: 43 Crossref: 44

Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection

Hye Soo Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Young Nyun Park, Dai Hoon Han, Kyung Sik Kim, Jin Sub Choi, Gi Hong Choi, Hyon-Suk Kim

Clin Mol Hepatol. 2020;26(1):33-44. Published online June 27, 2019

DOI: https://doi.org/10.3350/cmh.2018.0073

View: 5847 Download: 183 Web of Science: 18 Crossref: 15

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next

Viewed By 5484	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4646	MAFLD: How is it different from NAFLD?
Viewed By 4390	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3605	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3554	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 78	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search